|
MATERIA MEDICA INCLUDING APPLIED ASPECTS
INTRODUCTION
The two-part syllabus has been designed with the objective of
delivering to the candidate the entire experience of basic and
applied aspects of Homoeopathic health-care applicable to the
discipline of Materia Medica. The representation reproduced
below will clarify the basic philosophical and conceptual
position to be taken to appreciate the syllabus.
MD-Part.I
takes the candidate on the journey from Man in health a Man in
disease. The ground that he has covered earlier in the
undergraduate course is gone over again but from a very
different clinical perspective. The integrated approach a
clinician needs to adopt will underlie the exposure to these
subjects. This will be facilitated since the candidate is
simultaneously doing his resident training and is seeing the
phenomena of health being transformed into disease in his
clinical studies. Having thus re-visited the basic sciences, the
candidate is now prepared to undertake the journey deeper into
the healing science and art attempting to come into more
intimate contact with the principles that Hahnemann identifies
as critical for the success of the ‘Operation Cure’.Hence we
should be very clear about the philosophical and conceptual
basis of the syllabus and the ground that we need to cover. We
should evolve matching methods and techniques that will
experientially deliver to the candidate the entire experience of
‘Healing’ in its Hahnemannian sense.
We must also
remember that unlike in Modern medicine, there can be no
standardization of Homoeopathic management of different clinical
conditions. All the same, we should be able to define a common
approach to the understanding of the condition and it is
expected that with the passage of time and accurate
documentation (which will follow the establishment of
Postgraduate education), an approach will evolve. Till then we
will be required to integrate our general understanding of the
clinical and pathological phenomena of disease with our
knowledge of Materia Medica and apply philosophical concepts to
evolve the approach. References to literature are thus, at best,
only general and constitute preliminary readings for take off.
The role of the guide and teacher will be paramount in evolving
guidelines.
BASIC CONCEPTS
Part — I has already dealt with the following areas: -
(1) Structural basis of health and disease (Anatomical
organization of man and its degeneration into structural
pathology)
(2) Functional basis of health and disease (Physiological
organization of man and its degeneration into patho-physiology)
(3) Psychological basis of health and disease and the abnormal
psychological processes which initiate abnormal mental and
psycho-physiological functioning
(4) The Concept of Man that the clinician needs in order to
function in the clinical setting
(5) The scientific and full use of the extended senses of
Clinical Investigations to unravel the hidden, often nascent
stage in the evolution of the disease
(6) Final integration of all of the above with the basic tenets
of Homoeopathic Philosophy.
(7) Integrating all the above phenomena to conceptualize the
study of Homoeopathic Materia Medica and its application from
health to disease.
Part—11 is
now poised to take the candidate to understand the application
of the above knowledge in terms of the following:
(1) Evolving an approach to the Definition of the Clinical
Problem
(2) Understanding the crucial role of documentation in the
scientific understanding of the clinical state and artificial
disease phenomena
(3) Possessing a sound understanding of the Bio-Psycho-Social
concept of etiopathogenesis and evolution of the disease
phenomena to integrate with the study of Materia Medica
(4) Evolving clinico-pathological correlations to grasp the
essence of the disease phenomena and integrate in terms of the
structural, functional and formal correlations of disease and
Materia Medica
(5) Understanding different eras & concepts of the earlier times
& their influence on the construction of Materia Medica.
(6) Learning the basics of Classification of Disease and
integrating these principles with the Hahnemannian approach to
understand the depth and extent of Homoeopathic remedies
(7) Integrating all of the above in the erection and appropriate
processing of the Hahnemannian Totality
(8) Application in terms of evolving suitable Materia Medica
portraits and utilization of the drug force in a correct manner
to complete the ‘Operation Cure’ as per Hahnemann’s directions
in Aphorism 2.
(9) Scope & Limitation of the current state of knowledge of
Homoeopathic Materia Medica with the demands of Clinical
Practice and Education
(10) Finally, the need for the physician to take on the role of
the ‘Unprejudiced Observer’ (Aphorism 6) while carrying out all
of the above actions.
Materia Medica
study at the postgraduate level will require a definite
methodology. The steps needs clear definition. The diagrams
below would give an overview of the place of Materia Medica in
our plan of study and the vast area of Materia Medica that we
are covering in the course. It should be clear that the purpose
of the study is to equip the physician with a Philosophy and a
Method and not cram him with facts that are possible to refer to
the books while at the bedside. Hence unlike conventional
syllabus at the undergraduate level, this Syllabus does not
carry the mandatory medicinal list. At the same time, groups of
remedies, which are commonly used, have been mentioned to be
taken up as illustrations for understanding and mastering the
philosophy, the methodology and the techniques of Materia Medica.
The presentation that follows is based on the pattern of the PG
notification. Should there be any confusion, reference to the
Fig 3 should be resorted to.
(I) BASIC MATERIA
MEDICA
(1) Science & Philosophy of Materia Medica:
Concept, understanding & philosophy of Materia Medica & its
evolution
This is based on a clear grasp of the following concepts and
principles:
a. Concept of Man Universe
b. Principles of Logic-Analysis and Synthesis
c. Law of Similars
d. Concept of Natural and Artificial Disease
e. Principle of Evolution, Causation and Concomitance
f. Concepts of Structure, Form and Function
g. Principles of classification of Data and categorization into
Generals and particulars
h. Concept of Totality
i. Concept of Relationships
Most of these concepts would have been covered in Part I of the
course but would need a reiteration while introducing the study
of Materia Medica
(2)Source of
Materia Medica, Drug proving and Collection of symptoms:
a. Source of Materia Medica:
Understanding the concept of the different sources of Materia
Medica, their scope & limitations and their utilisation &
importance in building up of totalities of drugs. Sources
—Toxicological, Drug Proving, Clinical, Chemical, Physical,
Biological properties.
b. Drug proving
Method, Recording, Reporting as laid down by Hahnnemann and
developed and modified by the later workers with the advantages
and limitations of their work.
c. Collection and Classification of Symptoms
Classifying the
symptoms based on general principles of analysis and synthesis
a. Classification & giving a meaning to data collected from
proving & different sources.
Systematic application of these concepts to the study of a
well-proved polychrests in the Homoeopathic Materia Medica
requires us to examine our source books in a critical manner
The following
method is found to be advantageous if observed meticulously:
(i) Each symptom is broken up and re-arranged under the Standard
Headings as under:
(A) Cause: This is identified and studied in great detail to
bring out the Characteristic Expression (effects) by
establishing horizontal correlates in a clear manner;
(B) Sphere & Scope of Effects: Sensations & Complaints in
General, Mental State, Regional Effects: Tissues, Organs &
Pathology;
(C) Circumstances of Aggravation & Amelioration: General as well
as Particular (Regional) with special emphasis on those which
run counter to the general modalities and thus serve us well as
important differential modalities;
(D) Characteristic particulars: Along with the modalities and
strict concomitants
(A) Circumstances of Aggravation & Amelioration: General as well
as Particular (Regional) with special emphasis on those which
run counter to the general modalities and thus serve us well as
important differential modalities;
(D) Characteristic particulars: Along with the modalities and
strict concomitants
(ii) The data in
the source books, which is normally arranged as per Locations is
re-arranged in 4 Columns — Psora, Sycosis, Tubercular, and
Syphilis.
(iii) Psora furnishes us not only with the fundamental base for
the Chronic Diseases, but it also determines its Characteristic
Expression by virtue of the Sensitivity it governs the
Concomitants it gives rise to. It is dominant in the functional
early phase of any illness and tends to fade out progressively
with the evolution and march of the disease through the next
phases of Sycosis, Tubercle and Syphilis (Terminal Phase). These
next three phases, in spite of their predilection to the
formation of structural alterations of a type specific to the
particular Miasm, have also an early functional phase, which has
to be identified clearly in the pathogenesis of every drug if we
are to cure effectively. Characteristic expressions of these
early functional phases can also be studied in the pathogenesis
of every drug and these furnish us with important guidelines to
effective Homoeopathic prescribing for the chronic case.
Causative Factors can be identified in all these 4 Miasmatic
Expressions. The effects produced by the Causative Factors(s)
are not necessarily limited to the Miasm with which we identify
it; these effects can spill over into other Miasms; these
effects can be classified as (i) Common to the Miasmatic Group
and (ii) Characteristic to the Drug; the latter Characteristic
Expressions are of special interest in the evolution of the
Portrait of Disease in the true Hahnemannian sense.
These evolutionary
aspects of the ‘Artificial Drug-Disease’ can be studied in an
effective manner only when we examine this re-classified (as per
(i) & (ii) above) data in the light of our present knowledge of
clinical pathology of diseases. When we do this, we are able to
establish rational horizontal cross-connections between the data
arranged and classified in the vertical columns representing
Psora, Sycosis, Tubercular and Syphilis.
A characteristic
and distinctive pattern emerges in our mind, which is derived
from the data in the source books of the Homoeopathic Materia
Medica. This is the Hahnemannian Totality, which we should
endeavor to create and store in our mind. It should guide us to
examine the Source Books in greater detail in search of specific
characteristics when we are confronted with a patient who
reminds us in a general way of the portrait of the disease of
the drug in question. No attempt should be made to remember or
memorize these specific symptoms in the Homoeopathic Materia
Medica, which is vast and proves to be a maze to the
uninitiated.
Hahnemann’s Concept of the ‘Portrait of Disease’ (Aphorism 6,
Organon of Medicine) and its miasmatic evolution from the
symptoms recorded in the Homoeopathic Materia Medica. Miasmatic
evolution of disease follows the following pattern:
Psora - Sycosis - Tubercular - Syphilis
c. Types of
Materia Medica
The various types of Materia Medicas available viz. Drug
provings, Key notes, Commentaries, Compendiums, Synopses
etc.-their evolution and their place in the current study needs
to be highlighted.
(3) Study of
Materia Medica:
Different Approaches as detailed in the following Paper: Kasad,
K. N.: Post-Graduate Teaching in Homoeopathy:
Homoeopathic Materia Medica
(i) Appendix B-2 of the “Principles and Practice of Homoeopathy:
Part I- Homoeopathic Philosophy and Repertorization”
by M. L. Dhawale (i) Transactions of the international
Homoeopathic
League, Triennial Congress,
New Delhi, 1967.
(A) Concept of Drug Picture:
Kent, Boger, Pulford, Harvey Farrington, Margaret Tyler,
Borland.
(B) Repertorial Techniques for the evolution of the Drug
Pictures from Symptoms
Note:
(1) The Approach to the Study of these Drugs should effectively
demonstrate the application of the Principles laid down in the
preceding Sections.
(2) Drugs should be studied in Groups, stressing the Common as
well as the differential features of the individual drugs
included in the Group.
(3) Study should lay stress on the Method and Approach and not
so much on Factual Knowledge, access to which, is really
provided by the Repertories. Examination, thus, would not be
primarily a Test of Memory but of the capacity to organize and
deal effectively with the mass of data presented by the
Homoeopathic Materia Medica.
(4) Drugs in Category I: These are to be studied systematically
to bring out the ‘Portrait of the Disease’ under standard
Headings (Method II, P. 7-8)with minimal emphasis on
Characteristic particulars. Acute as well as Chronic Prescribing
Totalities with their Relationships are to be stressed. Full
Questions on the Group or individual members of the Group may be
asked in the Paper.
(5) Drugs in Category II: These are to be studied in a more
restrictive manner, stressing their Prescribing Totalities in
the spheres In which the drug is commonly employed. Here stress
is more often on the Characteristic. Particulars; important
Generals, where they are clearly established, however, are not
to be neglected. Standard I-leadings under Method I (P.7) should
be followed here. None of these drugs shall form the topic for a
full question in the Paper.
CATEGORY.I
CATEGORY.II
I. Congestive Group
Aco.n
Glonoine
Bell.
Stram, (Comp. Verat, .Alb.)
Hyosc.
Verat. vir.
Ferrum met,
Ferrum phos.
2. Injuries, Rheumatic States, Neuralgias
Arn. mont
Rhododendron
Rhustox. (Comp. other Rhus)
Kalmia
Bry.
alb.
Ledum
Puls.n. (Comp. KaIi sulph and
Cyclamen) Hyper.
Phytolacca
Symph.
Cimicifuga
Bellis p.
Eup.perf (Comp. Eup. pur.)
Guaiacum
Coffea
Ruta g.
Urtica urens
Stront. carb.
Dulcamara
Sanicula
Sanguinaria
Spigelia
Ranunculus b& s
Plantago m
3.Spasmodic & Irritable Group
Cham.
Cicuta V.
Cina
Dioscorea
Coloc.
Viburnum
Staph.
Caulophyllum
Nux.vom.
Lyssin
Cup. met. (Comp. Verat. aib)
Cup. ars.
Secale cor.
4. Urinary
Drugs
Canth. (Comp. Merc.cor)
Cannabis indica & sat.
Apis mel
Capsicum
Berberis v.
Sarsaparilla
5.Digestive
Drugs
Verat.alb.(Comp.Camph.,
Cup. Aethusa
SecaleCor.&Carb.veg.)
Ipecac.
Anacardium
Rheum
Chelid. m.
Leptandra
Cadmium met. & Sulph.
6. Rectal Drugs
Aloes
Aesculus
Hammamelis
Ratanhia
Podophyllum
Collinsonia
7. Respiratory
Drugs
Upper Respiratory Tract
Allium cepa
Arum t.
Euphrasia
Sabadilla
Cistus
Sambucus
Sticta Pulmonalis
Spasmodic
Cough
Drosera
Coccuscact
Corallium rubrum, Pertussin
Loose Cough
Rumex
Senega
Hydrastis
Lobelia
Stannum iod.
Stannum
Met
Collapse
Antimony
crud. & tart.
Ipecac
Ammonium carb(Comp.Ars.alb)
Antimony ars.
8. Heart Drugs
Digitalis
Ars. lod.
Strychnine Ars.& Phos.
Cactus g.
Laurocerasus
Lycopus
Lactrodectus m.
9. Debility Group
China
Chin. ars.
Phos.
ac.
Picric acid
Mur.
ac.
Selenium
Uranium nitrate
10. Natrum Group
Natrum carb.
Natrum ars.
Natrum mur.
Natrum iod.
Natrum phos.
Natrum h.
Natrum suiph.
Borax
Thuja
Sycotic Drugs
Medorrhinum
11. Kali Group
Kah carb.
Kali ars.
Kali bichrom.
Kali brom.
Kali mur.
Kali.iod
Kali Sulph.
Chlor.
Causticum (Comp. phos.)
12. Calcarea
Group
Calc. carb.
Calc. ars.
Calc. Phos.
Calc. sil
Calc. Flour.
Calc. Sulplh.
Calc. iod.
13. Baryta
Group
Baryta carb.
Baryta mur.
Baryta iod.
14. Magnesia
Group
Mag. Carb.
Mag. Mur.
Mag. Phos.
Mag. SuIph
15. Alumina,
Silica and Carbon Group
Alumina
Alumen
Silica
Carb.A
n
Carb.
veg.
Graph.
Petroleum
Sanicula
16. Phosphorus
and Tuberculins
Phos. (Comp. Causticum)
Tuberculinum bovinum
Aviare
Bacillinum
17. Mercury
Group and Antisyphilitics
Mercurius
sol.
Merc. Sul.
Mercurius cor.
Cinnaberis
Merc. Cyan.
Merc. Dul.
Asafoetida
Merc. iod. Fl.
Merc.iod. R.
Mezereum
Hep. Sul.
Nitric acid
Aurum
met.
Aurum mur.
Ars.Alb.
Aurum mur. N.
Ars. iod.
Fluoric acid
Ars. Sul.
Kali iod.
Syphilinum
18. Snake
Venoms & Sepsis
Lachesis
Crotalus c.
Crotalus h
Cenchris
Naja
Bothrops 1.
Baptisia
Vipera
Pyrogen
Elaps
Echinecia
Carbolic acid
Tarent. C.
Anthraxinum
Staphylococin
B. Coli
Diptherinum
19. Spider Venoms
Tarent
h.
Tarent. C.
Latrodectus m.
Aranea d.
Mygale
Theridion
20. Argentum Group & Related Drugs
Arg. Nit.
Murex
Arg.
Met.
Lilium tig.
Gelsemium
S
Sabadilla
Sepia
Sabina
21. Hysterical
Group
Ignatia
Valeriana off.
Nux moschata
Croc. sat.
Platina
Sumbul
Lac. C.
22. Paralytic Group
Camphor
Agaricus
Conium
Coca
Helleborus
Cocculus
Opium
Lathyrus sat.
Plumbum
Manganum
Zincum
Tabacum
23. Halogen
Groups & Related Drugs
Iodine
Chlorum
Bromium
Spongia
Badiag a
Thyroidinum
24.
Miscellaneous
Cadmium phos.
Cobaltum
Radium brom.
Radium iod.
X-Rays
25. Uterine
Group
Sabina
Bovista
Trillium
Caulophyllum
Viburnum
Thlaspi bursa pastoris
26. Lycopodium
(Comp. Berb. v. and Chelid.)
27. Sulphur
Sulphur iod.
28. Psorinum
29. Kreosote
(4) Sources of
Drug Family or Group Characteristics and drug relationship:
Study of Animal, Mineral, Plant group in general. Deeper
knowledge’s about individual source and drug properties not
required accept very prominent. Family & group Symptoms of
prominent classified group in different kingdom should be
focussed, more focussing on frequently coming group
characteristics.
1. Physiologic, Pharmacologic & Toxicologic Role: Importance and
Derivations in respect of Sphere and Scope in the Pathogenesy.
2. Concept of the Group: Its Identification & Differentiation.
3. Members’ of the Group’: Identification— Specific General
Expression.
(A) ANIMAL
KINGDOM
Mammalia MOSCHUS, Castoreum,Oleum animale, Hippomanes,
Castor equi, Lac vaccinum, La
defloratum, Lac caninum, Koumyss ,
Vertabrata
Fel tauri, Fel vulpi,Pulmo vulpis
Ophidia LACHESIS, CROTALUS,Bothrops, Agkistrodon, Elaps,
Naja, Vipera
- Pisces oleum jecorisi aselli.
Batrachia Bufo rana
Mollusca
SEPIAE SUCCUS, Murex.
Radiata Ccorallium rubrum, SPONGIA, Medusa,
Hemiptera coccus cacti, amex.
Hymenoptera APIS MELLIFICA, Vespa, Formica.
Artriculata
Coleoptera CANTHARIS.
Orthoptera Blatta
Arachnida Tarentula, Mygale,Theridion, Aranea.
(B) VEGETABLE KINGDOM
• Apocynaceae
• Loganiaceae
• Araceae
• Anacardiaceae
• Compositae
• Melanthaceae
• Menispermaceae
• Papaveraceae
• Cucurbitaceae
• Coniferae
• Euphorbiaceae
• Ranunculaceae
• Rubiaceae
• Scrophulariaceae
• Solanaceae
• Umbelliferae
(C) CHEMICAL APPROACH TO THE STUDY OF HOMOEOPATHIC MATERIA
1. General Validity: Relationship to Pathogenesy.
2. Anion & Cation Groupings: Relationship to the Periodic table
& Reflections in the Pathogenesy.
3. Physiologic, Pharmacologic & Toxicologic Rote: Importance and
Derivations in respect of Sphere and Scope in the Pathogenesy.
4. Concept of the ‘Group’: Its Identification & Differentiate
5. Members’ of the Groups: Identification — Specific General
Expression.
6. ‘Salts’ in the ‘Members’: Specific Expression: individuality
7. Relationship of Pathogenesy of Drugs Thom ft Plant and Animal
Kingdom to the Chemical Constituents.
8. Anion Groups: They are derivations from the
Pathogenesy of the Element and its impact on the Pathogenesy of
the Cation.
(a) Carbons (Carbo
animals, Carbo vegetabilis, Graphites, Petroleum, Kreosote, Carb.
sulphuratum) and Carbonates,
(b) Acids and
Halogens: General Introduction
i. Acids: General Properties
ii. Sulphuric, Sulphurous
iii. Nitric & Nitrates; Hepar sulph.
iv. Muriatic & Phosphoric; China
v . Picric & Picrates
vi. Acetic & Acetates
vii. Chromic & Chromates
viii. Formic & Formaldehyde
(a) Halogens:
general Properties
i.Fluoric Acid & Fluorides
ii.Chlorides & Chlorates
iii.Bromine & Bromides
iv.Iodine & lodides
(b) Sulphur,
Sulphides, Sulphates
i. Sulphur iodide
ii. Psorinum
iii. Selenium
iv. Sanicula
(c) Phosphorus and Phosphates
i. Tuberculinum
(d) Arsenic and
Arsenates
i. Arsenious Iodide
ii. Antimony
(e) Silica and
Silicates
i. Alumina
9. Alkali
Group; General Features
i. Lithium
ii. Natrums
iii. Kali.s
10. Alkaline Earths : General Features
i. Beryllium
ii. Magnesium
iii. Calcarea
iv. Lycopodium
v. Strontium
vi. Baryta
11.Radio-active
Group: General Features
i. Radium
ii. Uranium Nitrate
iii. X-Ray
iv. Magnet, North Pole, South Pole
12. Ferrum Group:
General Features
i. Ferrum
ii. Chromium
iii. Magnanum
iv. Cobalt
v Niccolum
vi. Cuprum
vii. Zincum
vii. Cadmium
13. Mercury Group:
General Features
i. Mercury
ii. Syphilinum
iii. Aurum
iv. Palladium
v. Thallium
vi. Plumbum
vii. Stannum
viii.Gelsemium
ix. Sepia
x. Murex
Relationship of Remedies (Boenninghausen
& Hering)
Concept of Related Totalities:
This has been stated in a most complete form by Boenninghausen
in his Section on Relationship in the Therapeutic Pocket Book.
The idea has been also developed by Hering, Clarke, Boger,
Miller and many others. The concept relates similar pictures to
each other, relates the main picture to splinter groups
(Sector-wise or Miasm-wise), projects sequential changes likely
to occur in the future under the influence of the selected
remedy, relates the main picture to the partial expressions of
Nosodes as anti-Miasmatic Drugs (Inter-currents) and also
stresses antidotal as well as inimical relationships derived
purely from clinical experience. Since this aspect of the
Homoeopathic Materia Medica is found to be extremely useful in
efficient Homoeopathic prescribing, training must provide a
through grounding in this.
Acute, Chronic, Complementary, Antidotes, Remedies that Follow
well, Inimicals, Sequences, Remedies that Precede well,
Inter-currents, Nosodes, Constitutional Remedy and its spectrum
of Acute Remedies.
1.Identification
of these Categories with suitable Examples;
2. Programming of Treatment based on these Concepts;
3. Technique of employing the Section in Boenninghausen’s
Therapeutic Pocket Book;
4. Follow-through of a Case on these lines;
Resolution of a mixed-up and complicated Case by adopting Vie
Technique of Splitting of the Totality into homogenous
components
Construction of
Materia Medica:
Classified Symptoms when arranged with a certain philosophical
background gives rise to different types of Materia Medica. Some
Materia Medica sources keep the symptom of prover as narrated;
others go on constructing Materia Medica from
clinicopathological point of view, utilize the principle of
generalization or emphasize the mental state & evolution of
symptoms. Some are based on comparison of remedy action, remedy
actions are presented in the commentary form or in the form of
keynotes, some carry a mixture of clinical experience and
proving depending upon the philosophy & experiences.Some keep
the evolutionary as well as the disease angle in focus and
attempt to relate the phenomena with the events in the life of
the individual. This gives a richly documented data comprising
of symptom-patterns to work upon and observe our remedies as
live people interacting with their world whilst going about
their business of living their lives. Such a unique mode of
study (termed as Living Materia Medica) has a lot in store for
us.
(5) Scope & Limitation of Materia Medica:
Scope and Limitations of different Materia Medicas as developed
by the different authors listed below:
I. Hahnemann
2. T.F.Allen
3. J.T.Kent
4. Hering
5. Farrington
6. C. M.Boger
7. John Clarke
8. M. L. Dhawale
9. George Vithoulkas
ID. R. Shankaran
II. S. R. Phatak
12. Whitmont
13. Catherine Coulter
(ii) COMPARATIVE MATERIA MEDICA
From symptomatic, regional location, closely coming drug picture
and group symptoms.
Comparisons:
General Principles & Applications:
(a) Therapeutic Groupings with Reportorial Correlations and
Differentiations
(b) Repertorial Syndromes: Concept and Differentiation
(c) Ailments from’ Rubrics from the Repertory:
Identification of the State Responsible and its Clinical
Evaluation
Effects Produced:
Evolution, Identification and Differentiation
Determination of the Prescribing Totality with the help of the
Concomitants (Associated Symptoms and Characteristics of the
Person).
In order to appreciate the application of the Materia medica at
the bedside, it is necessary to appreciate the concept of acute
totality as follows:
Concept of the
Acute Totality:
Hahnemann regards acute diseases, which are not mere episodes as
an explosion of Psora. From this follows the recommendation to
give an anti-Psoric after the acute phase is over or to consider
these whenever an acute disease runs an aberrant course. From
this it would appear that the acute and chronic totalities have
a certain definite relationship. These will be considered later
on. We could consider Acute Totality under the following
divisions:
(i) Acute General
Totality: Portion of the Chronic Totality capable of expression
in the acute phase .
(a) Causation and its Expression (Sensation and Complaints in
General joined
to Aggr & Amel)
(b) Mental State: Characteristic Expression with <&>
(c) Fevers: Stages: Chill, Heat, Perspiration with Causation,
Characteristic
Expression, <& > and Compound Fevers:
(ii) Sector Totality: Local Regional affinities are considered
here.
Chief Complaint(s): Locations
Pathology
Characteristic Expression: Cause
Sensations
<&>
Concomitants
Note:
1.Acute General Totality manifests itself much earlier in the
pre-localization phase of the acute illness and although its
expression varies within certain limits, it has a general
consistency in its expression which permits us to identify the
remedy not only in the early phases of the acute illness but
also in the later stages, irrespective of the variations in the
regional involvement(s).
2. Sector Totality
varies as per involvement of the regions and takes time to
evolve. In the later phases it may extend to involve other
regions. With the advance of the disease, It tends to lose its
specific characteristic expression while gaining in diagnostic
expression. Differentiation. thus, becomes increasingly
difficult with the advance of the disease.
3. Evolutionary
aspects of both must be appreciated in depth as well as extent
as at times these alone may furnish the guideline for
prescribing.
4. Prescribing
acute totality (ies) represents a combination of acute General
as well as acute Sector totalities and thus present in actual
practice a large number of pictures’ —all traceable to the same
drug. This can be quite bewildering unless the above divisions
| 
